Abiopharma

🔍 Hayden John W. (Executive)

Company: REINSURANCE GROUP OF AMERICA INC (RGA)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 407 shares of Restricted Share Unit - March 2026 (Derivative)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 407.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 1,174 shares of Stock Appreciation Right (right to purchase) 2026 at $200.5 per share (Derivative)
  Date: 2026-03-19 | Code: A | Expires: 2036-03-19 | equity_swap_involved: 0 | shares_owned_after: 1,174.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Stock appreciation rights and restricted share units settle in common stock, vest in 33 1/3% increments, beginning on the first anniversary date of the grant, and fully vest on March 19, 2029.
• REMARKS: This Form 4 is being filed late due to inadvertent administrative error.